You just read:

EIP Pharma announces scientific publication of results demonstrating pro-cognitive effects in aged rats of VX-745, a clinical stage selective p38 MAP kinase alpha Inhibitor

News provided by

EIP Pharma LLC

Dec 16, 2015, 08:00 ET